BioSpace News Archive

Single-use technology has come up as one of the prominent technologies in the sector of pre-commercial manufacturing, which comprises both clinical and pre-clinical scales.

The rising awareness about health and fitness is a prime factor augmenting the growth of the global B2B sports nutrition market.

Enterprise Therapeutics Ltd, a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, announced it has successfully dosed the first subjects in a Phase 1 trial for its novel inhaled cystic fibrosis therapy, ETD001.

Hummingbird Bioscience announced that its Chief Scientific Officer and co-founder, Dr Jerome Boyd-Kirkup, will be speaking at the 2021 virtual symposium “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond”, taking place on June 18, 2021.

OraSure Technologies, Inc. announced that it is collaborating with the Will Rodgers Liver Health Foundation to increase awareness around the role Hepatitis C plays in chronic liver disease and promoting testing services for HCV within the United States.

Aurinia Pharmaceuticals Inc. announced the appointment of Dr. Brinda Balakrishnan, M.D., Ph.D., to the Company’s Board of Directors effective June 14, 2021.

Novavax, Inc., announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial.

Ampio Pharmaceuticals announced details on the Company’s poster presentation, “Pivoting From One to Multiple Production Platforms to Treat COVID,” being given at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo in Boston, Massachusetts from November 1st to 3rd, 2021.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey O’Brien, JD/MBA, Vice President and Executive Officer, will participate in a fireside chat hosted by Maxim Group LLC Analyst Jason McCarthy, Ph.D., Senior Managing Director, Biotechnology, on Wednesday, June 23, 2021 at 1:00 pm ET.

Global WholeHealth Partners Corp., a company that offers one of the largest lines of COVID 19 tests, including SARS-CoV-2 viruses, and that states that its Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses, announced that they will now be able to distribute and sell Johnson & Johnsen’s COVID-19 vaccine.